contract_award•Awarded Monday, September 28, 2026Analyzed

LEIDOS BIOMEDICAL RESEARCH INC: $484M Department of Health and Human Services Contract

Bullish

Summary

Leidos Holdings ($LDOS) received a $484M delivery order from NIH to support National Cancer Institute operations for FY26-FY27. This represents approximately 1.6% of Leidos' annual revenue, reinforcing its role in federal healthcare IT and research support.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.Leidos secures $484M NIH task order for NCI operations.
  • 2.The award represents ~1.6% of Leidos' annual revenue, a meaningful but not transformative boost.
  • 3.No directly related legislation identified; the contract appears to be a routine operational renewal.

Market Implications

The contract underscores the federal government's continued investment in cancer research infrastructure. For $LDOS, this adds predictable revenue through 2027. The broader healthcare IT sector may see similar opportunities as NIH maintains its operational support contracts.

Full Analysis

The Department of Health and Human Services, through the National Institutes of Health, awarded a $484M delivery order to Leidos Biomedical Research Inc. for operational support of the National Cancer Institute over fiscal years 2026-2027. This task order covers a two-year period and is a continuation of Leidos' long-standing support for NCI operations. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. ($LDOS), a publicly traded technology and engineering company with $15.3B in annual revenue (FY2025). The $484M award translates to roughly $242M per year, or about 1.6% of Leidos' top line—a meaningful but not transformative contribution. No directly related legislation was identified among the provided bill signals; the contract appears to be a routine operational renewal funded through existing appropriations. Subcontractor details are not publicly available, but Leidos typically engages a network of small and mid-sized IT and research support firms for such task orders. Historically, Leidos has consistently won large NIH task orders, contributing to steady revenue growth in its health segment without causing major stock price swings given the company's size and diversification.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$LDOS▲ Bullish
Est. $242.0M – $242.0M revenue impact
①

What the bill does

Direct award of delivery order to subsidiary Leidos Biomedical Research Inc.

②

Who must act

Department of Health and Human Services (NIH) awarding to Leidos Biomedical Research Inc.

③

What happens

$484M added to backlog over two years, representing approximately $242M per year or 1.6% of annual revenue.

④

Stock impact

Leidos is a diversified technology and engineering company; this contract reinforces its position in federal health IT and biomedical research support, a core segment of its health business.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderSep 29, 2026

Streamlining Access to Government Services Through America.gov

The executive order directs the General Services Administration to create America.gov, a unified digital portal for federal services, integrating Login.gov for authentication and requiring agencies to expose their digital services via APIs. It also mandates the use of AI (referred to as 'super intelligence') with transparency safeguards, while preserving existing service channels and excluding tax and defense/intelligence services.

Exec OrderSep 18, 2026

Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program

This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.

proclamationSep 18, 2026

Restriction on Entry of Certain Nonimmigrant Workers

This proclamation extends for an additional 12 months the existing restriction on entry of H-1B nonimmigrant workers, which requires a $100,000 payment per petition (with limited exceptions) and is supported by a DHS weighted selection process that prioritizes higher-skilled, higher-paid workers. The action continues to target IT staffing and outsourcing firms that have abused the program, and it maintains the requirement for ongoing rulemakings by DHS and DOL to further reform wage protections and program integrity.

Contract Details

Recipient

LEIDOS BIOMEDICAL RESEARCH INC

Award Amount

$483,791,548

Awarding Agency

Department of Health and Human Services

Sub-Agency

National Institutes of Health

Contract Type

DELIVERY ORDER

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →